个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Mao Yimin[1] * ; Ma Shiwu[2] ; Liu Chenghai[3] ; Liu Xiaoyan[4] ; Su Minghua[5] ; Li Dongliang[6] ; Li Yiling[7] ; Chen Gongying[8] ; Chen Jun[9] ; Chen Jinjun[10] ; Zhao Jingmin[11] ; Guo Xiaoyan[12] ; Tang Jieting[1] ; Zhuge Yuzheng[13] ; Xie Qing[14] ; Xie Wen[15] ; Lai Rongtao[14] ; Cai Dachuan[16] ; Cai Qingxian[9] ; Zhi Yang[1] ; Li Xiaoyun[1] ;
机构： [1]Division of Gastroenterology and Hepatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, NHC Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Shanghai, 200001, China. maoym11968@163.com. [2]Department of Infectious Diseases, The 920th Hospital of Chinese PLA Joint Logistics Support Force, Kunming, 650032, Yunnan, China. [3]Institute of Liver Diseases, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. [4]Department of Pharmacy, Huangpu Branch of the 9th People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, 200011, China. [5]Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China. [6]Department of Hepatobiliary Medicine, The 900th Hospital of Chinese PLA Joint Logistics Support Force, Fuzhou, 350025, Fujian, China. [7]Department of Gastroenterology, First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China. [8]Department of Liver Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, 310015, Zhejiang, China. [9]Department of Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, 518112, Guangdong, China. [10]Hepatology Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. [11]Department of Pathology and Hepatology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China. [12]Department of Gastroenterology, Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710004, Shaanxi, China. [13]Department of Gastroenterology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210008, Jiangsu, China [14]Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China [15]Center of Liver Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, 100088, China [16]Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, China.
出处：
DOI： 10.1007/s12072-023-10633-7
ISSN：

关键词： Drug Herbal and dietary supplements Liver injury Guideline Management Diagnosis Treatment Prevention Phenotypes Prognosis

摘要：
Drug-induced liver injury (DILI) is an important adverse drug reaction that can lead to acute liver failure or even death in severe cases. Currently, the diagnosis of DILI still follows the strategy of exclusion. Therefore, a detailed history taking and a thorough and careful exclusion of other potential causes of liver injury is the key to correct diagnosis. This guideline was developed based on evidence-based medicine provided by the latest research advances and aims to provide professional guidance to clinicians on how to identify suspected DILI timely and standardize the diagnosis and management in clinical practice. Based on the clinical settings in China, the guideline also specifically focused on DILI in chronic liver disease, drug-induced viral hepatitis reactivation, common causing agents of DILI (herbal and dietary supplements, anti-tuberculosis drugs, and antineoplastic drugs), and signal of DILI in clinical trials and its assessment.© 2024. Asian Pacific Association for the Study of the Liver.

基金：
National Key R&D Program of China (Grant number 2022YFC3502101), the Major Project of National Thirteenth Five Plan (Grant number 2017ZX09304016), and the National Natural Science Foundation of China (Grant numbers NSFC 81970513 and NSFC 82270619), all to Yimin Mao.
语种：
外文
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类 | 2 区 医学
小类 | 3 区 胃肠肝病学
最新[2025]版：
大类 | 1 区 医学
小类 | 2 区 胃肠肝病学
JCR分区：
出版当年[2022]版：
Q1 GASTROENTEROLOGY & HEPATOLOGY
最新[2023]版：
Q1 GASTROENTEROLOGY & HEPATOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者：
第一作者机构： [1]Division of Gastroenterology and Hepatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, NHC Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Shanghai, 200001, China. maoym11968@163.com.
通讯作者：
推荐引用方式(GB/T 7714)：
Mao Yimin,Ma Shiwu,Liu Chenghai,et al.Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update[J].Hepatology International.2024,doi:10.1007/s12072-023-10633-7.
APA：
Mao Yimin,Ma Shiwu,Liu Chenghai,Liu Xiaoyan,Su Minghua...&Li Xiaoyun.(2024).Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update.Hepatology International,,
MLA：
Mao Yimin,et al."Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update".Hepatology International .(2024)

相关文献

[1]Liver injury in COVID-19: clinical features and treatment management. [2]Dietary supplements and herbal medicine for COVID-19: A systematic review of randomized control trials. [3]Clinical characteristics and prognosis of non-APAP drug-induced acute liver failure: a large multicenter cohort study [4]2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseases [5]Expert consensus on diagnosis, treatment and fertility management of young breast cancer patients [6]The Prevention and Treatment of Restenosis in The Era of Drug-eluting Stent [7]Evaluation of Lauge-Hansen Classification for Ankle Fractures and Follow-up Management [8]The role of non‑coding RNAs in the regulation, diagnosis, prognosis and treatment of osteosarcoma (Review). [9]Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis. [10]Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter study.

资源点击量：2020 今日访问量：0 总访问量：646 更新日期：2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持：重庆聚合科技有限公司 地址：广州市越秀区大德路111号